Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 5, p. 1, doi. 10.1007/s11912-018-0686-x
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2018 AND VI 20 AND IP 5
Results: 6
1
2
Current Concepts in the Treatment of Resectable Pancreatic Cancer.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 5, p. 1, doi. 10.1007/s11912-018-0685-y
- By:
- Publication type:
- Article
3
Current and Emerging Therapeutic Targets for Metastatic Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 5, p. 1, doi. 10.1007/s11912-018-0684-z
- By:
- Publication type:
- Article
4
Targeted Agents in Cervical Cancer: Beyond Bevacizumab.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 5, p. 1, doi. 10.1007/s11912-018-0680-3
- By:
- Publication type:
- Article
5
Single-Cell RNA-Sequencing in Glioma.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 5, p. 1, doi. 10.1007/s11912-018-0673-2
- By:
- Publication type:
- Article
6
Mesenchymal Chondrosarcoma: a Review with Emphasis on its Fusion-Driven Biology.
- Published in:
- Current Oncology Reports, 2018, v. 20, n. 5, p. 1, doi. 10.1007/s11912-018-0668-z
- By:
- Publication type:
- Article